# Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

> **NCT03319082** · — · UNKNOWN · sponsor: **Glaukos Corporation** · enrollment: 200 (estimated)

## Conditions studied

- Corneal Ectasia

## Interventions

- **COMBINATION_PRODUCT:** Corneal Collagen Cross-linking

## Key facts

- **NCT ID:** NCT03319082
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-04
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03319082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03319082, "Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03319082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*